Website profiles · Technology insights · Alternatives

certara.com

A complete cheminformatics workbench for molecule design, property calculation, search, data management, and more.

No paid content found Multilingual
Visit website
Profile views 17 Outbound visits 16 Normal
Chemaxon | Cheminformatics Software For Drug Discovery Full homepage screenshot

At a glance

Category
Science & Research
Language
English
Paid-content signal
No paid content foundObserved
Registered
2005
Hosting
CloudflareInferred
HTTPS certificate trusted
PassedObserved
Last updated

Website review

This review may include AI-generated content and is not individually verified. Domain, certificate and other facts come from the observed data on this page.

What is Chemaxon?

Chemaxon is a cheminformatics software provider focused on chemical and biological data handling, best known for tools that help scientists draw, store, search and analyse chemical structures. It is part of Certara, a drug development solutions company whose wider portfolio covers data-driven modelling, AI and predictive simulation.

What it is used for

  • Chemical structure drawing and editing
  • Structure and substructure searching in compound databases
  • Standardising and registering chemical data
  • Property prediction and cheminformatics workflows
  • Integrating chemistry data into research and discovery pipelines

Who it suits

Chemaxon is typically aimed at medicinal chemists, computational chemists, informatics teams and software developers in pharmaceutical and life-science organisations. It is also relevant to academic and industrial research groups that need reliable chemical data handling rather than general-purpose drawing tools.

Trade-offs

Its strength lies in depth: standardised formats, search capabilities and integration options suited to professional discovery workflows. That same depth can mean a steeper learning curve and more setup effort than simple drawing apps. Pricing is not stated in the supplied information, so cost should be confirmed directly with the vendor.

What is Chemaxon used for in drug discovery?

Chemaxon provides cheminformatics software used across drug discovery to represent, organize and analyze chemical structures and related data. Its tools typically handle tasks such as drawing and editing molecules, managing compound libraries, calculating molecular properties, and preparing datasets for modeling or screening.

Common uses include:

  • Structure handling: Drawing, editing and standardizing chemical structures.
  • Data management: Organizing compound and assay data in searchable chemical databases.
  • Property prediction: Estimating physicochemical and ADMET-related descriptors.
  • Virtual screening support: Filtering and preparing compound sets for docking or similarity searches.
  • Collaboration and reporting: Sharing chemical information through standardized formats.

Audiences are mainly medicinal chemists, computational chemists, informatics teams and data scientists in pharmaceutical and biotech research. The trade-off is that cheminformatics platforms demand structured, well-curated data and specialist training; they add most value where large compound collections or reproducible analysis pipelines exist. Smaller teams may find lighter drawing tools sufficient.

For broader context on drug development software, Certara is the parent organization associated with this offering: Certara.

What cheminformatics software tools does Chemaxon offer?

Chemaxon, part of Certara, provides cheminformatics software aimed at drug discovery, chemical data handling and structure-based workflows. Its tools generally fall into a few practical categories.

Core tool areas

  • Structure drawing and editing: desktop and web-based editors for creating and sharing chemical structures and reactions.
  • Data management and searching: chemical database and registration tools for storing, deduplicating and querying large compound collections.
  • Property prediction and calculation: modules for physicochemical properties, drug-likeness and related descriptors.
  • Format handling and integration: toolkits and APIs that let developers embed chemical structure handling into existing platforms and pipelines.
  • Naming and representation: utilities for converting between chemical names, structures and standard formats.

Who uses them

These tools are typically suited to medicinal chemists, computational chemists, data scientists and software teams building chemistry-aware applications. A research group may use the drawing tools for day-to-day work, while an enterprise may rely on the database and toolkit products to standardise compound data across departments.

Trade-offs

The main advantage is breadth: drawing, data handling and prediction can come from one vendor, which reduces integration friction. The trade-off is that Chemaxon products are generally commercial and oriented toward organisations with established discovery workflows, rather than casual or purely academic users. For concrete product names, editions and platform support, consult the official site: Chemaxon and Certara.

How does Chemaxon integrate with Certara's drug development solutions?

Chemaxon operates under Certara, and its cheminformatics tools are used alongside Certara's broader drug development offering. The relationship is best understood as complementary rather than a single merged platform: Chemaxon focuses on chemical structure handling, while Certara's wider portfolio covers data-driven modelling, AI and predictive simulation across the development pipeline.

Where Chemaxon fits

  • Chemical structure representation, drawing and standardisation
  • Cheminformatics workflows that feed compound data into modelling and simulation
  • Support for research teams working on drug discovery and lead optimisation

How integration typically works

In practice, integration is usually at the data and workflow level. Chemical structures and related properties generated through Chemaxon tools may be passed into Certara's modelling and simulation environments, so the same compound definitions inform downstream predictions. Organisations often combine them when they need both reliable chemistry handling and quantitative pharmacology or simulation capability.

Audiences and trade-offs

This combination is suited to discovery and development teams in pharmaceutical and biotech settings that already depend on structured chemical data. The main trade-off is complexity: teams gain a connected cheminformatics-to-simulation path, but may need to manage data exchange, format consistency and licensing across separate products. Smaller groups focused only on structure editing may find the broader Certara suite more than they need.

For official details on capabilities and compatibility, see Certara and Chemaxon.

Who can benefit from Chemaxon's cheminformatics software?

Chemaxon's cheminformatics software is designed for people who work with chemical structures and the data attached to them, particularly in life-science research and development. It is part of Certara's broader drug development offering, which combines modelling, AI and predictive simulation.

Primary audiences

  • Medicinal and computational chemists who need to draw, search, compare and analyse molecular structures.
  • Drug discovery teams that manage compound libraries, track structure–activity relationships and support lead optimisation.
  • Pharmaceutical and biotech organisations integrating chemistry data into wider R&D workflows.
  • Academic and institutional researchers in chemistry, pharmacology and related fields.

Other possible users

  • Data and informatics specialists who build or maintain chemical databases and need reliable structure handling.
  • Regulatory and safety teams that deal with chemical identifiers, properties or naming standards.
  • Software developers embedding chemistry functionality into scientific applications through APIs or toolkits.

The main trade-off is specialisation. These tools are powerful for structure-centric tasks, but they are not general-purpose data platforms, and smaller teams may find them more capable than they need. Organisations already using Certara's modelling and simulation tools may benefit from closer integration across discovery and development. Exact editions, deployment options and pricing are not specified in the available information, so interested users should confirm those details directly with the vendor.

What types of data analysis and modeling can Chemaxon perform?

Chemaxon provides cheminformatics tools used across drug discovery and chemical research. Its software typically supports:

  • Structure handling and standardization – parsing, drawing, and cleaning chemical structures; generating identifiers and canonical forms.
  • Property prediction – estimating physicochemical and ADME-related properties such as solubility, permeability, and lipophilicity from structure.
  • Descriptor and fingerprint calculation – producing numerical descriptors for machine learning, similarity searching, and clustering.
  • SAR and scaffold analysis – organizing compound series, detecting substructures, and comparing analogs.
  • Database searching and registration – exact, substructure, and similarity queries over compound collections.
  • Reaction and retrosynthesis support – representing transformations and enumerating possible routes.

These capabilities suit medicinal chemists, computational chemists, and data scientists who need to turn structural data into decisions. The trade-off is that predictions are model-based estimates, not experimental measurements, so they are best used for prioritization and hypothesis generation. Integration with broader modeling and simulation workflows is possible through Certara, which positions these tools within drug development solutions. Exact modules, limits, and pricing are not specified here.

Related questions

More questions →
What is certara.com?
A complete cheminformatics workbench for molecule design, property calculation, search, data management, and more.
Does certara.com offer paid content?
Unknown.
What languages does certara.com support?
Primary language: English. Multiple languages are available.
How can I visit certara.com?
Use the Visit website link to open the website in a new tab.
What are some alternatives to certara.com?
Related websites include zotero.org, zooniverse.org, zenodo.org, wvquine.org, wswa.org.au, wsgs.wyo.gov. Compare their features and pricing for your needs.

Website Overview

An established domain and managed infrastructure suggest continuity of operations and may support dependable delivery, although neither guarantees service quality. Page metadata, canonical configuration and social previews work together to provide more consistent search and sharing presentation.

Domain and Registration

Registered in 2005, this domain has about 21 years of history. That suggests continuity, although ownership and purpose may have changed. Transfer-protection status is present, helping reduce the risk of unauthorized domain transfers. The registrar is GoDaddy.com, LLC, a widely used domain service provider. The domain uses the common .com extension, which is not an independent safety signal.

DNS and Email

Nameservers are provided by NS1, indicating managed DNS hosting. MX records point to the Microsoft 365 email service. SPF and DMARC are configured. DKIM status is unknown. TXT records include verification markers for Google, Apple, Atlassian. Such markers may also remain after a service stops being used. DNSSEC signatures were not detected, so this additional DNS authenticity protection is not confirmed.

TLS and Certificates

The public key uses EC with 256 bits. The server supplied a complete certificate chain. No organization name is present in the certificate; the available fields are consistent with domain validation. The certificate was issued within the Google Trust Services cloud or CDN ecosystem. The certificate's total validity is about 90 days, consistent with a short renewal cycle.

HTTP and Browser Security

X-Powered-By exposes backend information: WP Engine. The checked browser-security headers were not detected, leaving fewer explicit browser-side safeguards. The cf-ray, x-cache response header indicates a CDN or caching proxy in the delivery path. No obvious internal addresses or debug information were found in the headers. The Server header identifies cloudflare without an exact version.

Technology Stack Analysis

The public page identifies Powered by WPBakery Page Builder - drag and drop page builder for WordPress., WordPress, jQuery, Google Tag Manager, Cloudflare without precise versions, leaving fewer clues for version-specific scanning.

Search and Social Sharing

The Generator tag identifies Powered by WPBakery Page Builder - drag and drop page builder for WordPress., making the publishing system easier to fingerprint. Twitter Card metadata is configured. JSON-LD includes Organization data, helping describe the organization as an entity. The page declares 4 language or regional alternatives using hreflang. The title has 36 characters, within a common display range.

Hosting and Email

DNSNS1
HostingCloudflare
EmailMicrosoft 365
Approximate IP geolocation (inferred; a CDN or proxy may differ from the origin server) United States flagUnited States Inferred 141.193.213.20

Registration details

RDAP / WHOIS

RegistrarGoDaddy.com, LLC
Registered2005-09-15
Expires2027-09-15
Domain statusclient delete prohibited、client renew prohibited、client transfer prohibited、client update prohibited
Nameserversdns1.p03.nsone.net、dns2.p03.nsone.net、dns3.p03.nsone.net、dns4.p03.nsone.net
DNSSECunsigned

DNS records

DNS

TypeNameValueTTLPriority
Acertara.com141.193.213.201204—
Acertara.com141.193.213.211204—
MXcertara.comcertara-com.mail.protection.outlook.com90010
NScertara.comdns1.p03.nsone.net43200—
NScertara.comdns2.p03.nsone.net43200—
NScertara.comdns3.p03.nsone.net43200—
NScertara.comdns4.p03.nsone.net43200—
TXTcertara.com8ZclvP73EV+VpU2Di0iQ5IzhG08M2VQpi9laFAykXIWzwe0lRc1B12ikuRgKrbFbHDcRk/2TdYzdQYEgrC6huA==3600—
TXTcertara.comZOOM_verify_fMlJOax9S1mRU6txQJh6Jw3600—
TXTcertara.comadobe-idp-site-verification=504203df83ff69d9be55acd05662eea1089f78f5ff72f4edc6b1f7044fd5a1e63600—
TXTcertara.comadobe-sign-verification=b2d5e611d0ce5cec122e0049ad285323600—
TXTcertara.comairtable-verification=797fa27453c5a9960961c72d4ec250233600—
TXTcertara.comanthropic-domain-verification-8ckkbj=1s6zB39e99QeIoweaRGV8qrnJ3600—
TXTcertara.comanthropic-domain-verification-mn3hnk=NGon2FWTsejymqUL0i2QsAHFq3600—
TXTcertara.comapple-domain-verification=JsCU4bJMemasZ8kl3600—
TXTcertara.comatlassian-domain-verification=QWfVXgfdUOkrKbLuYVdjQBcyRj3P9mBNuhxAaa825RTGSU3Fa29FpcScgEBwGMXt3600—
TXTcertara.comatlassian-domain-verification=TufEKVplHMcadgFuNMurswxSVGllFel/fvdTrRwuUhp5sma1H8uHt2jnS3FUsaQg3600—
TXTcertara.comatlassian-domain-verification=jB0XTlmD17g1NWqUUijI0fNRQFlCi3OAqRsGud8WtGaOVbIHhTG2bP4BGLlVv/CB3600—
TXTcertara.comatlassian-domain-verification=uB9DxIy01jGqvbLxb346B0YEgyuoLBU0J4ZDa89kC/ou1Hb9yAjUVlQKrh/PylcF3600—
TXTcertara.combox-domain-verification=dea82724504e5240b29107224e77e60bf992cecef4dc7da1ff21cdfc3b04134b3600—
TXTcertara.comca3-5107bbc2444f4108b720a1fd4911cacd3600—
TXTcertara.comcursor-domain-verification-g9m1bn=yIHIqFHIQxGsIuw7oX0Ak28Fu3600—
TXTcertara.comdocusign=843c7cc9-2824-4f16-a567-4c902414816e3600—
TXTcertara.comdropbox-domain-verification=wrmk8ci2pdxa3600—
TXTcertara.comg-p-domain-verification-dxd309=pLix9JUVbxZVGXz0EIbBQAkff3600—
TXTcertara.comgoogle-site-verification=-vgnnfJltPsDDQDV_ZEf6FDQVBX9UOVToxR_KoYjUv03600—
TXTcertara.comgoogle-site-verification=LSHt1DocFLQIE50HG2WCzkC_8xKDxtHjTGIH6OcTFiY3600—
TXTcertara.comgoogle-site-verification=M_jm4bvVqOQWjdOadxFbeekTBkrtsYDtTmtzY4rf9ZE3600—
TXTcertara.commiro-verification=a1b3a2c5e06c428565d5aed15184b2621a9b27b53600—
TXTcertara.comopenai-domain-verification=dv-o7hQE2F41GtHvO2VSy5uTX6X3600—
TXTcertara.comopenai-domain-verification=dv-zr7vfcnIyf9vBa2uEkPUNHWx3600—
TXTcertara.compmxroadmap.azurewebsites.net3600—
TXTcertara.comsmartsheet-site-validation=NzP62jp1544DJ07pyAy46pHqNJSyzbYz3600—
TXTcertara.comsmartsheet-site-validation=fYBVcw34QonHgd26jFTfbsQowqqayXB23600—
TXTcertara.comv=spf1 include:spf.protection.outlook.com include:44520764.spf07.hubspotemail.net ip4:192.160.145.0/24 ip4:199.15.213.0/24 ip4:63.76.85.128/25 ip4:4.79.253.226/32 -all3600—
TXTcertara.comwebexdomainverification.4C675B87A30DB136E053AB06FC0A3F65=54d11980-70e3-4dbd-b65c-192eac02bf753600—
TXTcertara.comwiz-domain-verification=79052b5cb2a5e3b51223467365a646fdc2b8bf64b5a073d0c052afaa42a22ec43600—
TXTcertara.comzenqms-domain-verification=9b1fd98e7c299c403df27f7331920e564062b46a858017f79a551d0a2d7cf8e6zenqms-domain-verification=9fd37ce545135d51bb84fbc549c473ab35f9e88a57ca23a3219ba089a3fd69f53600—
CNAMEwww.certara.comcertara.com3600—
DMARC_dmarc.certara.comv=DMARC1; p=reject; rua=mailto:[email protected]; ruf=mailto:[email protected]3600—

TLS and certificates

TLS / SSL

AssessmentNormal configuration
Supported protocolsTLSv1.2、TLSv1.3
Negotiated protocolTLSv1.3
Certificate subjectwww.certara.com
IssuerGoogle Trust Services
Valid until2026-11-30T06:31 · Remaining when checked: 68 days
Verification detailsCertificate trust: Passed · Hostname match: Passed

HTTP response headers

HTTP

HeaderValue
content-typetext/html; charset=UTF-8
cache-controlmax-age=600, must-revalidate
servercloudflare

Identified technologies

Powered by WPBakery Page Builder - drag and drop page builder for WordPress.WordPressjQueryGoogle Tag ManagerCloudflare

Pages, Search and Sharing

Meta descriptionCertara's transformative drug development solutions include data-driven modelling, AI and predictive simulation. Accelerate your development process for good
Canonical URLhttps://www.certara.com/
LanguageEnglish (default) · Multilingual
Twitter Cardsummary_large_image
googlebot 1 allowed · 0 disallowed
  • Allow/
All bots 0 allowed · 6 disallowed
  • Disallow/wp/wp-admin/
  • Disallow/wp/wp-includes/js/jquery/jquery.js
  • Disallow/27554-2/
  • Disallow/4a-decision-framework/
  • Disallow/why-phoenix-nlme-is-the-best-in-class-solution-for-pop-pkpd/
  • Disallow/payment/

Recent Updates

  • HTTP Response Information

User reviews (0)

  • No reviews yet.